Viewing Study NCT04262869


Ignite Creation Date: 2025-12-24 @ 11:09 PM
Ignite Modification Date: 2026-03-11 @ 4:02 PM
Study NCT ID: NCT04262869
Status: WITHDRAWN
Last Update Posted: 2021-10-27
First Post: 2020-02-07
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Platinum-Based Chemotherapy and Durvalumab for the Treatment of Stage IIIB or IV Non-small Cell Lung Cancer
Sponsor: Emory University
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2020-03-27
Start Date Type: ACTUAL
Primary Completion Date: 2021-10-18
Primary Completion Date Type: ACTUAL
Completion Date: 2021-10-18
Completion Date Type: ACTUAL
First Submit Date: 2020-02-07
First Submit QC Date: None
Study First Post Date: 2020-02-10
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2021-10-26
Last Update Post Date: 2021-10-27
Last Update Post Date Type: ACTUAL